{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:36:33Z","timestamp":1773095793120,"version":"3.50.1"},"reference-count":13,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2022,10,15]]},"DOI":"10.1080\/10428194.2022.2100369","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T07:38:22Z","timestamp":1658734702000},"page":"3008-3011","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin"],"prefix":"10.1080","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4332-0891","authenticated-orcid":false,"given":"Tiffany","family":"Guan","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Services, University of California, San Francisco Medical Center","place":["San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, University of California, San Francisco Medical Center","place":["San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, University of California, San Francisco Medical Center","place":["San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyun","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/BMT, University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Boulbol","sequence":"additional","affiliation":[{"name":"Community Cancer Institute, Community Medical Center","place":["Clovis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanson","family":"Mouanoutoua","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, Fresno Campus","place":["Fresno, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Chu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalambos","family":"Andreadis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/BMT, University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/BMT, University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifaa","family":"Abdulhaq","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, Fresno Campus","place":["Fresno, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Fakhri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/BMT, University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"Seattle Genetics. ADCETRIS (brentuximab vedotin) [package insert]. U.S. Food and Drug Administration; 2020 [updated 2017 Nov; cited 2020 Dec 12]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/125388s094lbl.pdf"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00102-2"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009178"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_238799"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-861641"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.002"},{"key":"e_1_3_2_8_1","unstructured":"National Comprehensive Cancer Network Guidelines. Hodgkin\u2019s lymphoma (2.2020); 2020; Plymouth Meeting PA."},{"key":"e_1_3_2_9_1","unstructured":"National Comprehensive Cancer Network Guidelines. B-cell lymphoma (4.2020); 2020; Plymouth Meeting PA."},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708984"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15586"},{"key":"e_1_3_2_12_1","volume-title":"American Thoracic Society 2019 International Conference","author":"Katta S","year":"2019","unstructured":"Katta S, Connolly T, et\u00a0al. Acute drug-induced pneumonitis from brentuximab therapy [conference presentation abstract]. American Thoracic Society 2019 International Conference; 2019 May 19; Dallas, TX."},{"key":"e_1_3_2_13_1","first-page":"2359437","article-title":"Severe acute pulmonary toxicity associated with brentuximab in a patient with refractory Hodgkin\u2019s lymphoma","volume":"2016","author":"Sabet Y","year":"2016","unstructured":"Sabet Y, Ramirez S, Cespedes ER, et\u00a0al. Severe acute pulmonary toxicity associated with brentuximab in a patient with refractory Hodgkin\u2019s lymphoma. Case Rep Pulmonol. 2016;2016:2359437.","journal-title":"Case Rep Pulmonol"},{"key":"e_1_3_2_14_1","volume-title":"Brentuximab vedotin [package insert]","year":"2011","unstructured":"Brentuximab vedotin [package insert]. Bothell (WA): Seattle Genetics, Inc.; 2011."}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2022.2100369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T19:49:14Z","timestamp":1738871354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2022.2100369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,10,15]]}},"alternative-id":["10.1080\/10428194.2022.2100369"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2022.2100369","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}